SAN JOSE, Calif. — ForteBio, the Biologics Business Unit of Molecular Devices, today announced that to aid in the discovery of human therapeutic antibodies to viral infections like dengue fever and eastern equine encephalitis, the Vanderbilt Vaccine Center recently became one of the first academic institutes in North America to adopt ForteBio’s Octet HTX system. A centerpiece in the Biopharm […]
Genedata Profiler used for biomarker discovery and validation projects in support of Chugai’s early proof of concept research initiatives Tokyo, Japan – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Chugai Pharmaceutical Co., Ltd., a leading research-based pharmaceutical company in Japan, has chosen Genedata Profiler® as one of the […]
We are proud to announce the first sale of the Biopixlar® platform to University of Canterbury, NZ. The sale goes to Dr. Yilei Zhang who will use Biopixlar for both research and education. In addition to the sale of the platform, University of Canterbury enters into a collaboration with Fluicell to act as a demo site for […]
Berlin-Germany and Utrecht, Netherlands The Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration at the Charité – Universitätsmedizin Berlin has installed a MILabs extra ultra-high resolution microCT (U-CT XUHR) system as an essential research tool to study the interplay between biology and mechanical strain. The unit will be used to to study the effects of […]
Lausanne-Switzerland and Utrecht-the Netherlands The University of Lausanne (UNIL) and the Lausanne University Hospital (CHUV) have acquired MILabs latest in-vivo optical imaging and diagnostic X-ray CT systems. The systems will be installed in the In-Vivo Imaging Facility (IVIF) and serve a dual optical imaging function. Aptly named the Duet Optical Imaging Module, the system can […]
NANJING, China and EMERYVILLE, Calif. — GenScript Biotech Corp., the world’s leading pharmaceutical CDMO company, announced today that the company is adopting a state-of-the-art optofluidic single-cell platform known as the Beacon® platform. The platform was developed by Berkeley Lights, Inc., a company committed to helping customers find the best cells to accelerate the use of cell-based products. […]
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) — Fluidigm (Nasdaq:FLDM) today announced that Covance, the drug development business of LabCorp® (NYSE: LH), a leading global life sciences company, has selected Fluidigm’s CyTOF® technology and the industry-leading Maxpar® Direct™ Immune Profiling Assay™ to develop highly multiplexed immune profiling services. Setting an industry first, high-multiplex mass cytometry enables clinical researchers to simultaneously profile […]
California-based drug discovery company Neuropore Therapies is using INTEGRA Biosciences’ EVOLVE, VIAFLO and VOYAGER pipettes to help accelerate research in both its in vitro and in vivo pharmacology departments. The company, which is dedicated to halting the progression of neurodegenerative diseases by targeting the core processes underlying these disorders, has been a long term supporter of INTEGRA, as a Neuropore scientist explained: “We initially started with just the VIAFLO […]
ANN ARBOR, Mich. –Swift Biosciences, Inc (“Swift”) and Helix OpCo, LLC (“Helix”) today announced a Partnership Agreement to leverage Swift’s 2S Turbo DNA library preparation for Helix’s Exome+™ assay. Helix, a population genomics company, uses the Exome+™ assay to power population health programs focused on accelerating the integration of genomics into clinical care and facilitating […]
Novasep, a leading supplier of services and technologies for the life sciences industry, announces Enzene Biosciences (India) has chosen BioSC® Pilot for purification of biopharmaceuticals to operate in its Pune plant. BioSC® Pilot is dedicated to the purification of biomolecules such as monoclonal antibodies (mAbs), from early pilot phase to small commercial production. It fits particularly […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
